Alendronate reduces serum TNF? and IL-1?, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis

Helen Α. Papadaki(University of Crete), George D. Eliopoulos(University of Crete), Maria Miliaki(University of Crete), Christos Tsatsanis(Unknown), Niki Malliaraki(University of Crete), Anna Christoforidou(University of Crete), Andrew N. Margioris(University of Crete), Maria Psyllaki(University of Crete)
Journal of Bone and Mineral Metabolism
October 14, 2004
10.1007/s00774-004-0526-y
Cited by 30

Related Papers

Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
|Proceedings of the National Academy of Sciences|2012|605
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389
Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti–tumor necrosis factor-α antibody therapy
|Blood|2002|266
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|154
Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha–mediated effect
|Blood|2002|138